Kisspeptin vs Tesamorelin
Kisspeptin and Tesamorelin are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: Kisspeptin is decapeptide (kisspeptin-10), kiss1 gene product fragment, while Tesamorelin is full-length 44-residue ghrh analogue with trans-3-hexenoic acid modification — different molecular classes with different handling consequences; their leading degradation routes differ (tryptophan oxidation, accelerated by light for Kisspeptin, aggregation at air–liquid interfaces from agitation for Tesamorelin), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
Kisspeptin — origin
Kisspeptin-10 is the C-terminal decapeptide of the KISS1 gene product, active at the KISS1 receptor (GPR54). It sits at the top of the reproductive signalling axis, studied for triggering GnRH release. The parent protein was first described as a metastasis suppressor, hence the older name metastin.
Tesamorelin — origin
Tesamorelin is the complete 44-amino-acid sequence of human growth hormone-releasing hormone with a trans-3-hexenoic acid group attached at the N-terminus. That modification exists for one reason: native GHRH is cleaved almost immediately by dipeptidyl peptidase-4 at the N-terminal end, and the hexenoyl group blocks that cleavage.
Kisspeptin research themes
Studied as the upstream trigger of GnRH release and the downstream LH and FSH signalling cascade.
Examined as the endogenous ligand for the KISS1 receptor in reproductive neuroendocrine models.
The parent KISS1 product was first characterised in cancer-metastasis research, a separate strand of the literature.
Tesamorelin research themes
Full-length GHRH activity with DPP-4 resistance conferred by the N-terminal modification.
The most distinctive endpoint in its research literature.
Studied for effects on endogenous GH secretion patterns rather than direct GH substitution.
Investigated alongside body-composition endpoints in metabolic research.
Kisspeptin handling
- Reach room temperature before opening.
- Keep reconstituted solution out of direct light during long bench sessions.
- Aliquot and refrigerate.
Tesamorelin handling
- Allow several minutes for dissolution; do not accelerate with agitation or heat.
- Swirl gently — long chains aggregate at interfaces.
- Do not freeze reconstituted solution.
Both third-party tested
Every Popular Peptides batch of Kisspeptin and Tesamorelin is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
Kisspeptin reference
Related comparisons
Kisspeptin and Tesamorelin are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.